Plasma LEAP-2 Following a Low-Calorie Diet with or without Interval Exercise in Women with Obesity
Ragland TJ, Malin SK. Plasma leap-2 following a low-calorie diet with or without interval exercise in women with obesity. Nutrients. 2023;15(3):655.
The authors used Phoenix’s human LEAP-2(38-77) EIA kit (Cat # EK-075-40) to demonstrate results.
Involvement of POMC neurons in LEAP2 regulation of food intake and body weight
Chu G, Peng H, Yu N, Zhang Y, Lin X, Lu Y. Involvement of POMC neurons in LEAP2 regulation of food intake and body weight. Front Endocrinol (Lausanne). 2022;13:932761.
The authors used Phoenix’s human LEAP-2(38-77) EIA kit (Cat # EK-075-40) to demonstrate results.
The Hunger Games: Homeostatic State-Dependent Fluctuations in Disinhibition Measured with a Novel Gamified Test Battery
Voigt K, Giddens E, Stark R, et al. The hunger games: homeostatic state-dependent fluctuations in disinhibition measured with a novel gamified test battery. Nutrients. 2021;13(6):2001.
The authors used Phoenix’s human LEAP-2(38-77) EIA kit (Cat # EK-075-40) to demonstrate results.
LEAP-2/ghrelin interplay in adult growth hormone deficiency: Cause or consequence? A pilot study
Vergani E, Bruno C, Gavotti C, et al. LEAP‐2/ghrelin interplay in adult growth hormone deficiency: Cause or consequence? A pilot study. IUBMB Life. 2021;73(7):978-984.
The authors used Phoenix’s human LEAP-2(38-77) EIA kit (Cat # EK-075-40) to demonstrate results.
Circulating LEAP-2 is associated with puberty in girls
Barja-Fernández S, Lugilde J, Castelao C, et al. Circulating LEAP-2 is associated with puberty in girls. Int J Obes.
The authors used Phoenix’s human LEAP-2(38-77) EIA kit (Cat # EK-075-40) to demonstrate results.
LEAP2 changes with body mass and food intake in humans and mice
Mani BK, Puzziferri N, He Z, et al. LEAP2 changes with body mass and food intake in humans and mice. Journal of Clinical Investigation. 2019;129(9):3909-3923.
The authors used Phoenix’s human LEAP-2(38-77) EIA kit (Cat # EK-075-40) to demonstrate results.
Levels of the Novel Endogenous Antagonist of Ghrelin Receptor, Liver-Enriched Antimicrobial Peptide-2, in Patients with Rheumatoid Arthritis
Francisco V, Tovar S, Conde J, et al. Levels of the novel endogenous antagonist of ghrelin receptor, liver-enriched antimicrobial peptide-2, in patients with rheumatoid arthritis. Nutrients. 2020;12(4):1006.
The authors used Phoenix’s human LEAP-2(38-77) EIA kit (Cat # EK-075-40) to demonstrate results.
Liver-expressed antimicrobial peptide 2 is associated with improved pancreatic insulin secretion in adults with overweight and obesity
Stark R, Feehan J, Mousa A, Andrews ZB, de Courten B. Liver-expressed antimicrobial peptide 2 is associated with improved pancreatic insulin secretion in adults with overweight and obesity. Diabetes Obes Metab. 2023;25(5):1213-1220.
The authors used Phoenix’s human LEAP-2(38-77) EIA kit (Cat # EK-075-40) to demonstrate results.
The dietary regulation of LEAP2 depends on meal composition in mice
Gradel AKJ, Holm SK, Byberg S, et al. The dietary regulation of LEAP2 depends on meal composition in mice. FASEB J. 2023;37(6):e22923.
The authors used Phoenix’s human LEAP-2(38-77) EIA kit (Cat # EK-075-40) to demonstrate results.
